DexCom
DXCM
C$115.12
Share price
-0.77%
Change (1 day)
-27.44%
Change (1 year)
Categories
DexCom (DXCM) - Total debt
Total debt on the balance sheet as of March 2025 : C$3.53 Billion
According to DexCom's latest financial reports the company's total debt is C$3.53 Billion. A company’s total debt is the sum of all current and non-current debts.
DexCom - Total debt on balance sheet (from 2006 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | C$3.71 B | 7.91% |
| 2023-12-31 | C$3.44 B | 18.21% |
| 2022-12-31 | C$2.91 B | 5.84% |
| 2021-12-31 | C$2.75 B | 17.25% |
| 2020-12-31 | C$2.34 B | 54.8% |
| 2019-12-31 | C$1.51 B | 9.31% |
| 2018-12-31 | C$1.38 B | 229.81% |
| 2017-12-31 | C$0.42 B | 4568.02% |
| 2016-12-31 | C$9 M | 182.2% |
| 2015-12-31 | C$3.19 M | -40.23% |
| 2014-12-31 | C$5.33 M | -26.25% |
| 2013-12-31 | C$7.23 M | 3.99% |
| 2012-12-31 | C$6.96 M | |
| 2010-12-31 | C$0.52 M | -98.93% |
| 2009-12-31 | C$49.09 M | -7.66% |
| 2008-12-31 | C$53.16 M | -14.6% |
| 2007-12-31 | C$62.25 M | 1667.05% |
| 2006-12-31 | C$3.52 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | C$0.95 B | -72.93% | 🇺🇸 USA |
 Becton Dickinson BDX | C$26.36 B | 645.97% | 🇺🇸 USA |
 West Pharmaceutical WST | C$0.41 B | -88.26% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | C$0.67 B | -80.91% | 🇺🇸 USA |
 Medtronic MDT | C$39.02 B | 1,003.90% | 🇮🇪 Ireland |
 Abbott Laboratories ABT | C$18.11 B | 412.62% | 🇺🇸 USA |
 Johnson & Johnson JNJ | C$71.49 B | 1,922.76% | 🇺🇸 USA |
 QuidelOrtho QDEL | C$3.68 B | 4.30% | 🇺🇸 USA |